Surveillance: 252 Real Stories

252 stories match surveillance. 199 of them mention surgery.

Joachim, who was diagnosed with Colorectal CancerColorectal Cancer

Colorectal Cancer: Joachim's Survivor Story

Patient Info: Joachim Braun, Male, 50s

As of early summer 2013, Joachim had completed surgery for early rectal cancer, needed no chemotherapy or radiation, returned to work, managed a permanent colostomy, and continued annual follow-up.

Krankheitserfahrungen.de
OutcomeSurvivorship / Completed Treatment
Lisa, who was diagnosed with Colorectal CancerColorectal Cancer

Colorectal Cancer: Lisa's Survivor Story

Patient Info: Lisa Roth, Female, 50s

Biomarkers: Lynch syndrome / HNPCC

By winter 2012/2013, Lisa was free of metastases and recurrence after surgery for Lynch syndrome-associated colorectal cancer, and she had become active in hereditary colorectal cancer self-help.

Krankheitserfahrungen.de
OutcomeCancer-Free / NED
Lorenz, who was diagnosed with Stage IV Colorectal CancerColorectal Cancer

Stage IV Colorectal Cancer: Lorenz's Patient Story

Patient Info: Lorenz Kraus, Male, 60s | Stage IV

Metastatic Site: Liver

By fall 2012, Lorenz was 3 years beyond sigmoid colon cancer diagnosis, had undergone surgery, chemotherapy, and 2 liver-metastasis operations, and recent liver findings had improved enough that he continued working and staying active.

Krankheitserfahrungen.de
OutcomeResponding Well
Sonja, who was diagnosed with Colorectal CancerColorectal Cancer

Colorectal Cancer: Sonja's Survivor Story

Patient Info: Sonja Novotny, Female, 50s

By spring 2013, Sonja had completed chemotherapy, radiation, surgery with temporary stoma, later stoma reversal, and rehabilitation, and she had returned gradually to work before later retiring.

Krankheitserfahrungen.de
OutcomeSurvivorship / Completed Treatment
Glenna, who was diagnosed with Stage IV Non-Small Cell Lung CancerLung Cancer

Stage IV HER2-Positive Non-Small Cell Lung Cancer: Glenna's Survivor Story

Patient Info: Glenna, Female | Stage IV

Biomarkers: HER2 mutation confirmed by blood and tissue biopsy biomarker testing

Stage IV HER2-mutated NSCLC with first-line chemotherapy failure, then ongoing Enhertu from September 2023 and official NED/no evidence of disease status.

Lung Cancer Research Foundation
OutcomeCancer-Free / NED
Lauren, who was diagnosed with Stage III Non-Small Cell Lung CancerLung Cancer

Stage III EGFR Non-Small Cell Lung Cancer: Lauren's Survivor Story

Patient Info: Lauren, Female, Under 40 | Stage III

Biomarkers: EGFR mutation

No evidence of cancer on 1-year scan after fertility preservation, chemotherapy, radiation, and removal of half the left lung for Stage III EGFR-mutated lung cancer.

Lung Cancer Research Foundation
OutcomeCancer-Free / NED
Kevin, who was diagnosed with Stage I Breast CancerBreast Cancer

Stage I Breast Cancer: Kevin's Patient Story

Patient Info: Kevin Jarvis, Male | Stage I

Biomarkers: Genetic testing inconclusive; receptor status not reported

Early male breast cancer treated with mastectomy, sentinel node biopsy, EC chemotherapy, paclitaxel/Taxol, and ongoing daily tamoxifen; latest source text describes good spirits and continued discussion of risk-reducing surgery, but does not explicitly state NED.

Cancer Council Australia
OutcomeCare Ongoing
Caroline, who was diagnosed with Lung CancerLung Cancer

EGFR Lung Cancer: Caroline's Patient Story

Patient Info: Caroline, Female

Biomarkers: Germline EGFR T790M mutation

Ongoing surveillance for germline EGFR T790M-associated lung nodules / lung cancer risk after October 2022 surgery and complications; the story does not support Stage IV disease for Caroline.

Lung Cancer Research Foundation
OutcomeCare Ongoing
Rebecca, who was diagnosed with Stage III Colorectal CancerColorectal Cancer

Stage III Colorectal Cancer: Rebecca's Survivor Story

Patient Info: Rebecca Barber, Female, Under 40 | Stage III

Completed treatment for Stage IIIB colorectal cancer, including chemotherapy, surgery with ileostomy/reversal, and radiation; ongoing issues include pain, LARS, neuropathy, anxiety, and survivorship support needs, with no explicit NED status stated.

Fight Colorectal Cancer
OutcomeSurvivorship / Surveillance
Marley, who was diagnosed with Stage IV Non-Small Cell Lung CancerLung Cancer

Stage IV ALK Non-Small Cell Lung Cancer: Marley's Patient Story

Patient Info: Marley, Female | Stage IV

Biomarkers: ALK-positive

Metastatic Site: Chest lymph nodes; axillary lymph nodes; lymph nodes…

Living with Stage IV ALK-positive NSCLC involving lymph nodes and malignant pleural fluid, with scans every 3 months; specific treatment regimen is not reported.

Lung Cancer Research Foundation
OutcomeLiving With Cancer
Gwen, who was diagnosed with Stage IV Colorectal CancerColorectal Cancer

Stage IV Colorectal Cancer: Gwen's Survivor Story

Patient Info: Gwen Powell, Female | Stage IV

Biomarkers: Biomarker testing performed; results not reported

Metastatic Site: Ovary; liver

Stage IV colon cancer with ovarian mass and liver metastasis treated with chemotherapy and surgeries including colostomy/reversal; she reported being almost 2 years NED while living with neuropathy and surveillance anxiety.

Fight Colorectal Cancer
OutcomeCancer-Free / NED
Julie, who was diagnosed with Stage I Lung AdenocarcinomaLung Cancer

Stage I EGFR Lung Adenocarcinoma: Julie's Patient Story

Patient Info: Julie, Female, 40s | Stage I

Biomarkers: EGFR exon 19 deletion

Ongoing care after Stage IB EGFR exon 19 lung adenocarcinoma treated with lower left lobectomy and Tagrisso/osimertinib, with CT and MRI surveillance; no recurrence/NED statement is explicitly provided.

Lung Cancer Research Foundation
OutcomeCare Ongoing
Robert, who was diagnosed with Stage II Colorectal AdenocarcinomaColorectal Cancer

Stage II Colorectal Adenocarcinoma: Robert's Survivor Story

Patient Info: Robert, Male | Stage II

High-risk Stage II colon adenocarcinoma treated with surgery removing the ascending colon and 10 cm of distal small bowel; latest source text supports survivorship after relatively early detection but does not explicitly state NED or no recurrence.

Fight Colorectal Cancer
OutcomeSurvivorship / Surveillance
Jameelah, who was diagnosed with Stage III Colorectal CancerColorectal Cancer

Stage III Colorectal Cancer: Jameelah's Survivor Story

Patient Info: Jameelah Mahmoud, Female, Under 40 | Stage III

No evidence of disease after laparoscopic colon surgery and 8 rounds of chemotherapy for Stage III colorectal cancer; remains in surveillance while processing visible and invisible survivorship scars.

Fight Colorectal Cancer
OutcomeCancer-Free / NED
Kelly, who was diagnosed with Colorectal CancerColorectal Cancer

Colorectal Cancer: Kelly's Patient Story

Patient Info: Kelly Brophy, Female

Family-reported colon cancer story: Kelly Brophy’s mother had early-stage colon cancer in 2011, later developed an inoperable colon mass found through screening in 2015, and died in 2017 at age 54.

Fight Colorectal Cancer
OutcomeIn Memory
Amber, who was diagnosed with Stage IV Colorectal CancerColorectal Cancer

Stage IV Colorectal Cancer: Amber's Survivor Story

Patient Info: Amber Madden, Female, 40s | Stage IV

Biomarkers: Comprehensive hereditary cancer genetic testing negative; tumor biomarkers not reported

Metastatic Site: Liver

Stage III colon cancer upstaged to Stage IV after liver metastasis was found; after colectomy, chemotherapy, liver surgery, and more chemotherapy, CT scans in May, August, and November 2025 showed no evidence of active cancer.

Fight Colorectal Cancer
OutcomeCancer-Free / NED
Pete, who was diagnosed with Stage III Colorectal CancerColorectal Cancer

Stage III Colorectal Cancer: Pete's Survivor Story

Patient Info: Pete Di Stefano, 40s | Stage III

Completed surgery and 3 months of FOLFOX chemotherapy for Stage IIIB transverse colon cancer; latest NED status is not reported, so this is best classified as survivorship / surveillance.

Fight Colorectal Cancer
OutcomeSurvivorship / Surveillance
Karina, who was diagnosed with Stage III Colorectal CancerColorectal Cancer

Stage III Colorectal Cancer: Karina's Survivor Story

Patient Info: Karina Bandera, Female, 40s | Stage III

Recovering after treatment for Stage IIIC rectal cancer, including chemotherapy, surgery, sepsis complication, ileostomy, more chemotherapy, and ileostomy reversal; she reported doing well, but explicit NED/remission status is not stated.

Fight Colorectal Cancer
OutcomeSurvivorship / Surveillance
Margaret, who was diagnosed with Stage I Colorectal CancerColorectal Cancer

Stage I Colorectal Cancer: Margaret's Survivor Story

Patient Info: Margaret Mullaney, Female | Stage I

Stage I colorectal cancer treated with surgery, followed by a 5-year surveillance plan and regular testing; chemotherapy and radiation are not described in the available story.

Fight Colorectal Cancer
OutcomeSurvivorship / Surveillance
Janice, who was diagnosed with Stage IV Colorectal CancerColorectal Cancer

Stage IV Colorectal Cancer: Janice's Patient Story

Patient Info: Janice Johnson, Female, 40s | Stage IV

Biomarkers: CEA tumor marker elevated after colectomy; biomarker/genomic test results not reported

Metastatic Site: Lungs

Ongoing care for Stage IV colorectal cancer after colectomy, years of chemotherapy, radiation, lung resections for metastatic disease, and pelvic stent exchanges every 3 months.

American Cancer Society
OutcomeCare Ongoing
Duane, who was diagnosed with Stage IV Non-Small Cell Lung CancerLung Cancer

Stage IV ALK Non-Small Cell Lung Cancer: Duane's Patient Story

Patient Info: Duane Steiner, Male, 50s | Stage IV

Biomarkers: ALK-positive / ALK gene mutation identified by molecular or genomic testing

Living more than 6 years with incurable Stage IV ALK-positive lung cancer, supported by targeted therapy, clinical-trial participation, Hope Lodge access, and periodic monitoring.

American Cancer Society
OutcomeLiving With Cancer
Donna, who was diagnosed with Non-Small Cell Lung CancerLung Cancer

EGFR Non-Small Cell Lung Cancer: Donna's Patient Story

Patient Info: Donna Thompson, Female, 40s

Biomarkers: EGFR-positive lung cancer reported during recurrence; initial tumor biomarker status not reported

Recurrent NSCLC after earlier Stage II surgery and limited chemotherapy; later EGFR-targeted therapy caused kidney failure, 2 new spots were radiated in July 2025, and new nodules are under watchful monitoring.

GO2 Foundation
OutcomeSetback / Progression
Usha, who was diagnosed with Stage IV Non-Small Cell Lung CancerLung Cancer

Stage IV Non-Small Cell Lung Cancer: Usha's Patient Story

Patient Info: Usha Jain, Female | Stage IV

Biomarkers: Tumor genetic profile available for navigation review, but specific results are not reported

Stage IV NSCLC after nearly 2 years of chemotherapy and immunotherapy, followed by watchful monitoring with routine scans; clinical trials were reviewed but not pursued.

GO2 Foundation
OutcomeCare Ongoing